Cue Biopharma, Inc. (CUE)
27.82
+5.49
(+24.59%)
USD |
NASDAQ |
Oct 09, 16:00
27.87
+0.05
(+0.18%)
After-Hours: 20:00
Cue Biopharma Price to Book Value : 62.98 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 50.55 |
| October 07, 2026 | 50.96 |
| October 06, 2026 | 52.38 |
| October 05, 2026 | 55.15 |
| October 02, 2026 | 57.89 |
| October 01, 2026 | 57.16 |
| September 30, 2026 | 58.56 |
| September 29, 2026 | 57.75 |
| September 28, 2026 | 62.14 |
| September 25, 2026 | 71.11 |
| September 24, 2026 | 74.37 |
| September 23, 2026 | 71.79 |
| September 22, 2026 | 69.95 |
| September 21, 2026 | 64.00 |
| September 18, 2026 | 83.87 |
| September 17, 2026 | 85.66 |
| September 16, 2026 | 77.35 |
| September 15, 2026 | 71.63 |
| September 14, 2026 | 69.16 |
| September 11, 2026 | 65.06 |
| September 10, 2026 | 63.39 |
| September 09, 2026 | 69.05 |
| September 08, 2026 | 67.91 |
| September 04, 2026 | 62.12 |
| September 03, 2026 | 62.64 |
| Date | Value |
|---|---|
| September 02, 2026 | 61.03 |
| September 01, 2026 | 64.38 |
| August 31, 2026 | 57.77 |
| August 28, 2026 | 63.12 |
| August 27, 2026 | 63.75 |
| August 26, 2026 | 65.31 |
| August 25, 2026 | 60.58 |
| August 24, 2026 | 52.48 |
| August 21, 2026 | 54.29 |
| August 20, 2026 | 55.71 |
| August 19, 2026 | 59.49 |
| August 18, 2026 | 58.18 |
| August 17, 2026 | 62.57 |
| August 14, 2026 | 77.42 |
| August 13, 2026 | 70.36 |
| August 12, 2026 | 68.87 |
| August 11, 2026 | 63.93 |
| August 10, 2026 | 59.09 |
| August 07, 2026 | 61.39 |
| August 06, 2026 | 61.15 |
| August 05, 2026 | 60.33 |
| August 04, 2026 | 60.22 |
| August 03, 2026 | 60.83 |
| July 31, 2026 | 60.76 |
| July 30, 2026 | 68.82 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Xilio Therapeutics, Inc. | 0.8268 |
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.96 |
| Savara, Inc. | 7.042 |
| Vericel Corp. | 5.544 |
Price to Book Value Related Metrics
| PS Ratio | 3.361 |
| PEG Ratio | -0.0035 |
| Price | 27.82 |
| Earnings Yield | -97.06% |
| Market Cap | 145.48M |
| PEGY Ratio | -0.0035 |